Protease inhibitor–induced lipodystrophy
- 1 April 1999
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 40 (4) , 635-636
- https://doi.org/10.1016/s0190-9622(99)70452-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Development of Cervical Fat Pads Following Therapy with Human Immunodeficiency Virus Type 1 Protease InhibitorsClinical Infectious Diseases, 1998
- Localized adipose tissue hypertrophy in patients receiving human immunodeficiency virus protease inhibitors.Clinical Infectious Diseases, 1998
- “Buffalo hump” in HIV-1 infectionThe Lancet, 1998
- Pseudo‐Cushing's Syndrome in Human Immunodeficiency Virus– Infected PatientsClinical Infectious Diseases, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Indinavir-associated lipodystrophyAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998
- A Short-Term Study of the Safety, Pharmacokinetics, and Efficacy of Ritonavir, an Inhibitor of HIV-1 ProteaseNew England Journal of Medicine, 1995